在治疗 3 岁以上髓母细胞瘤患儿方面采用 SJMB 方案的国际经验(文献综述)

Q4 Medicine
A. S. Levashov, S. Zagidullina, T. T. Valiev, A. Stroganova, Dmitry A. Khochenkov, V. Grigorenko, E. V. Mikhaylova, Elizaveta V. Tyurina, M. Ryzhova, Serhii Horielyshev, Shavkat U. Kadyrov, V. Polyakov
{"title":"在治疗 3 岁以上髓母细胞瘤患儿方面采用 SJMB 方案的国际经验(文献综述)","authors":"A. S. Levashov, S. Zagidullina, T. T. Valiev, A. Stroganova, Dmitry A. Khochenkov, V. Grigorenko, E. V. Mikhaylova, Elizaveta V. Tyurina, M. Ryzhova, Serhii Horielyshev, Shavkat U. Kadyrov, V. Polyakov","doi":"10.26442/18151434.2023.3.202437","DOIUrl":null,"url":null,"abstract":"During the last 30 years, unique international experience has been accumulated in the treatment of children with medulloblastoma, especially in the age group over 3 years. Evolutionary representations about one of the most well – known international protocols – SJMB (in versions since 1996 – SJMB96, since 2003 – SJMB03, since 2012 – SJMB12) are shown in this article. Innovative criteria for stratifying patients into risk groups were established according to clinical, therapeutic, morphological and molecular-biological prognostic factors. Despite the accumulated experience, it is necessary to continue studying the relationship between age groups and the molecular biology of tumor cells for the purpose of subsequent optimization of the treatment program.","PeriodicalId":16401,"journal":{"name":"Journal of Modern Oncology","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"International experience by using of the SJMB protocols in treatment of children with medulloblastoma in the age group over 3 years (literature review)\",\"authors\":\"A. S. Levashov, S. Zagidullina, T. T. Valiev, A. Stroganova, Dmitry A. Khochenkov, V. Grigorenko, E. V. Mikhaylova, Elizaveta V. Tyurina, M. Ryzhova, Serhii Horielyshev, Shavkat U. Kadyrov, V. Polyakov\",\"doi\":\"10.26442/18151434.2023.3.202437\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"During the last 30 years, unique international experience has been accumulated in the treatment of children with medulloblastoma, especially in the age group over 3 years. Evolutionary representations about one of the most well – known international protocols – SJMB (in versions since 1996 – SJMB96, since 2003 – SJMB03, since 2012 – SJMB12) are shown in this article. Innovative criteria for stratifying patients into risk groups were established according to clinical, therapeutic, morphological and molecular-biological prognostic factors. Despite the accumulated experience, it is necessary to continue studying the relationship between age groups and the molecular biology of tumor cells for the purpose of subsequent optimization of the treatment program.\",\"PeriodicalId\":16401,\"journal\":{\"name\":\"Journal of Modern Oncology\",\"volume\":\"5 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Modern Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26442/18151434.2023.3.202437\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Modern Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26442/18151434.2023.3.202437","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

近30年来,国际上在治疗成神经管细胞瘤儿童,特别是3岁以上儿童方面积累了独特的经验。本文展示了最著名的国际协议之一- SJMB(自1996年以来的版本- SJMB96,自2003年以来的版本- SJMB03,自2012年以来的版本- SJMB12)的演变表示。根据临床、治疗、形态学和分子生物学预后因素,建立了将患者划分为危险组的创新标准。尽管积累了经验,但仍有必要继续研究年龄组与肿瘤细胞分子生物学的关系,以便后续优化治疗方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
International experience by using of the SJMB protocols in treatment of children with medulloblastoma in the age group over 3 years (literature review)
During the last 30 years, unique international experience has been accumulated in the treatment of children with medulloblastoma, especially in the age group over 3 years. Evolutionary representations about one of the most well – known international protocols – SJMB (in versions since 1996 – SJMB96, since 2003 – SJMB03, since 2012 – SJMB12) are shown in this article. Innovative criteria for stratifying patients into risk groups were established according to clinical, therapeutic, morphological and molecular-biological prognostic factors. Despite the accumulated experience, it is necessary to continue studying the relationship between age groups and the molecular biology of tumor cells for the purpose of subsequent optimization of the treatment program.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Modern Oncology
Journal of Modern Oncology Medicine-Oncology
CiteScore
0.50
自引率
0.00%
发文量
0
审稿时长
5 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信